Q4 2025 Earnings Call February 11, 2026 5:00 PM ESTCompany ParticipantsJames Samford - Head of Investor RelationsChad ...
Q4 2025 Earnings Call February 11, 2026 5:30 PM ESTCompany ParticipantsPhillip Konieczny - Senior Vice President of ...
Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results